Lmr Partners LLP Krystal Biotech, Inc. Transaction History
Lmr Partners LLP
- $9.66 Billion
- Q4 2024
A detailed history of Lmr Partners LLP transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 2,500 shares of KRYS stock, worth $443,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 5,000
50.0%
Holding current value
$443,425
Previous $909,000
56.99%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$700 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$511 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$466 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$227 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$156 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.55B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...